| How much is too much high-dose cytosine arabinoside? |
| TP Duffy |
|
JCO May 1 1985: 601–603.
[PDF]
|
 |
| Homoharringtonine as a new antileukemic agent |
| T Ohnuma and JF Holland |
|
JCO May 1 1985: 604–606.
[PDF]
|
 |
|
Cytosine-arabinoside-induced colitis and peritonitis: nonoperative management |
| |
H Johnson, TJ Smith, and J Desforges |
| |
JCO May 1 1985: 607–612.
[Abstract]
[PDF]
|
 |
|
Cerebellar toxicity following high-dose cytosine arabinoside |
| |
LA Dworkin, RD Goldman, LS Zivin, and PC Fuchs |
| |
JCO May 1 1985: 613–616.
[Abstract]
[PDF]
|
 |
|
Homoharringtonine: an effective new drug for remission induction in refractory nonlymphoblastic leukemia |
| |
RP Warrell, Jr, CJ Coonley, and TS Gee |
| |
JCO May 1 1985: 617–621.
[Abstract]
[PDF]
|
 |
|
Central nervous system morbidity following an initial isolated central nervous system relapse and its subsequent therapy in childhood acute lymphoblastic leukemia |
| |
JJ Ochs, G Rivera, RJ Aur, HO Hustu, R Berg, and JV Simone |
| |
JCO May 1 1985: 622–626.
[Abstract]
[PDF]
|
 |
|
Curability of Burkitt's lymphoma with high-dose cyclophosphamide-high- dose methotrexate therapy and intrathecal chemoprophylaxis |
| |
MP Sullivan and I Ramirez |
| |
JCO May 1 1985: 627–636.
[Abstract]
[PDF]
|
 |
|
The significance of the residual mediastinal mass in treated Hodgkin's disease |
| |
M Jochelson, P Mauch, J Balikian, D Rosenthal, and G Canellos |
| |
JCO May 1 1985: 637–640.
[Abstract]
[PDF]
|
 |
|
Superoxide anion (O-2) production by peripheral blood monocytes in Hodgkin's disease and malignant lymphoma |
| |
R Perez-Soler, G Lopez-Berestein, F Cabanillas, P McLaughlin, and EM Hersh |
| |
JCO May 1 1985: 641–645.
[Abstract]
[PDF]
|
 |
|
Renal involvement in diffuse aggressive lymphomas: results of treatment with combination chemotherapy |
| |
DB Geffen, RI Fisher, DL Longo, RC Young, and VT DeVita, Jr |
| |
JCO May 1 1985: 646–653.
[Abstract]
[PDF]
|
 |
|
Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma |
| |
JJ Costanzi, MR Cooper, JH Scarffe, H Ozer, SS Grubbs, RW Ferraresi, RB Pollard, and RJ Spiegel |
| |
JCO May 1 1985: 654–659.
[Abstract]
[PDF]
|
 |
|
Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer |
| |
D Stefanik, R Goldberg, P Byrne, F Smith, W Ueno, L Smith, L Bachenheimer, C Beiser, and A Dritschilo |
| |
JCO May 1 1985: 660–665.
[Abstract]
[PDF]
|
 |
|
Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial |
| |
JD Hainsworth, SD Williams, LH Einhorn, R Birch, and FA Greco |
| |
JCO May 1 1985: 666–671.
[Abstract]
[PDF]
|
 |
|
A randomized trial of adjuvant chemotherapy in head and neck cancer |
| |
SG Taylor, 4th, E Applebaum, JL Showel, M Norusis, LD Holinger, JC Hutchinson, Jr, AK Murthy, and DD Caldarelli |
| |
JCO May 1 1985: 672–679.
[Abstract]
[PDF]
|
 |
|
Intraocular retinoblastoma group V: an analysis of prognostic factors |
| |
CM Rubin, LL Robison, JD Cameron, WG Woods, ME Nesbit, Jr, W Krivit, TH Kim, RD Letson, and NK Ramsay |
| |
JCO May 1 1985: 680–685.
[Abstract]
[PDF]
|
 |
|
Ewing's sarcoma in bones of the hands and feet: a clinicopathologic study and review of the literature |
| |
SK Shirley, FB Askin, LA Gilula, TJ Vietti, PR Thomas, GP Siegal, WR Reinus, JM Kissane, and ME Nesbit |
| |
JCO May 1 1985: 686–697.
[Abstract]
[PDF]
|
 |
|
Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft- tissue sarcomas of the extremities |
| |
SA Rosenberg, CA Seipp, DE White, and R Wesley |
| |
JCO May 1 1985: 698–709.
[Abstract]
[PDF]
|
 |
|
Complications and management of implanted venous access catheters |
| |
JJ Lokich, A Bothe, Jr, P Benotti, and C Moore |
| |
JCO May 1 1985: 710–717.
[Abstract]
[PDF]
|
 |
|
Immunogenicity of hepatitis B vaccine in oncology patients receiving chemotherapy |
| |
AB Weitberg, SA Weitzman, E Watkins, C Hinkle, S O'Rourke, and JL Dienstag |
| |
JCO May 1 1985: 718–722.
[Abstract]
[PDF]
|
 |
|
Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy |
| |
JE Cantrell, Jr, TM Phillips, and PS Schein |
| |
JCO May 1 1985: 723–734.
[Abstract]
[PDF]
|
 |
|
Drug-induced antibodies during 2-N-methyl-9-hydroxyellipticinium acetate (NSC-264137) treatment: schedule dependency and relationship to hemolysis |
| |
JM Mondesir, JM Bidart, A Goodman, GF Alberici, P Caille, F Troalen, J Rouesse, C Bohuon, RJ Gralla, and AI Einzig |
| |
JCO May 1 1985: 735–740.
[Abstract]
[PDF]
|
 |
| The flip flop pump syndrome |
| D Prager, R Attilio, and R Riether |
|
JCO May 1 1985: 741.
[PDF]
|
 |